Synopsis
Synopsis
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
1. Allegra
2. Alpha-(4-(1-carboxy-1-methylethyl)phenyl)-4-hydroxydiphenylmethyl-1-piperidinebutanol
3. Fexofenadine
4. Mdl 16,455a
5. Mdl 16.455
6. Mdl 16455
7. Mdl-16455
8. Telfast
1. 153439-40-8
2. Fexofenadine Hcl
3. Allegra
4. Telfast
5. 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic Acid Hydrochloride
6. Mdl 16,455a
7. 138452-21-8
8. Fexofenadine (hydrochloride)
9. Mdl 16455
10. Mdl-16455a
11. Terfenadine Carboxylate Hydrochloride
12. 2s068b75zu
13. Mdl 16455a
14. 2-(4-{1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic Acid Hydrochloride
15. 2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic Acid;hydrochloride
16. 153439-40-8 (hcl)
17. Dsstox_cid_28642
18. Dsstox_rid_82912
19. Dsstox_gsid_48716
20. Allegra Allergy
21. Allegra Hives
22. Smr000718798
23. Cas-153439-40-8
24. Ncgc00015453-05
25. Children's Allegra Hives
26. Fexofenidine Hydrochloride
27. Children's Allegra Allergy
28. Terfenidine
29. Altiva
30. Unii-2s068b75zu
31. Carboxyterfenadine Hydrochloride
32. Allegra Flash
33. Sr-01000075889
34. Allegra Od
35. Fexofenadine Hydrochloride [usan]
36. Fexofenadine, Hcl
37. Allegra (tn)
38. Terfenidine Carboxylate Hydrochloride
39. Mfcd00865710
40. Fexofenadine Hydrochloride [usan:usp]
41. Fexofenadina Cloridrato
42. Fexofenadine-d10 Hcl
43. Cloridrato De Fexofenadina
44. Clorhidrato De Fexofenadina
45. Chlorhydrate De Fexofenadine
46. Mdl-16455 Hydrochloride
47. Schembl40914
48. Mls001306422
49. Mls001332493
50. Mls001332494
51. Fexofenadine Impurity Standard
52. Spectrum1504179
53. Chebi:5051
54. Chembl1200618
55. Dtxsid5048716
56. Hy-b0801a
57. Fexofenadine Hydrochloride- Bio-x
58. Pharmakon1600-01504179
59. Tox21_113125
60. Nsc758678
61. S3208
62. Akos015907422
63. Tox21_113125_1
64. Ab07499
65. Ccg-213275
66. Cs-4483
67. Fexofenadine Hydrochloride (jp17/usp)
68. Fexofenadine Hydrochloride [mi]
69. Ks-1057
70. Nc00724
71. Nsc 758678
72. Nsc-758678
73. Fexofenadine Hydrochloride [jan]
74. Ncgc00015453-02
75. Ncgc00015453-08
76. Ncgc00092389-01
77. Ncgc00095906-01
78. Ncgc00095906-02
79. (+-)-p-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidino)butyl)-alpha-methylhydratropic Acid Hydrochloride
80. Ac-24745
81. Bf164454
82. Fexofenadine Hydrochloride [mart.]
83. Fexofenadine Hydrochloride [vandf]
84. Fexofenadine Hydrochloride [usp-rs]
85. Fexofenadine Hydrochloride [who-dd]
86. Fexofenadine Hydrochloride, >98% (hplc)
87. Db-043190
88. A3371
89. F0698
90. Ft-0631183
91. M-016455-o
92. Sw199568-2
93. Bim-0050472.0001
94. D00671
95. Fexofenadine Hydrochloride [orange Book]
96. Fexofenadine Hydrochloride [ep Monograph]
97. Fexofenadine Hydrochloride [usp Impurity]
98. 452f218
99. Fexofenadine Hydrochloride [usp Monograph]
100. J-505843
101. Sr-01000075889-6
102. Allegra-d Component Fexofenadine Hydrochloride
103. Q27255526
104. Fexofenadine Hydrochloride 100 Microg/ml In Acetonitrile
105. Fexofenadine Hydrochloride Component Of Allegra-d
106. Z2210694607
107. Fexofenadine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
108. Fexofenadine Hcl, Pharmaceutical Secondary Standard; Certified Reference Material
109. Fexofenadine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
110. (+/-)-p-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidino)butyl)-.alpha.-methylhydratropic Acid, Hydrochloride
111. 2-(4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic Acid Hcl
112. 2-(4-{1-hydroxy-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butyl}-phenyl)-2-methyl-propionic Acid
113. 2-(4-{1-hydroxy-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butyl}-phenyl)-2-methyl-propionic Acid; Hydrochloride;fexofenadine Hcl
114. 4-[(4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic Acid Hydrochloride
115. 4-[4-[4-(hydroxydiphenylmethyl)-1-pieridinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic Acid Hydrochloride
116. 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic Acid Hydrochloride
117. Benzeneacetic Acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-.alpha.,.alpha.-dimethyl-, Hydrochloride, (+/-)-
118. Benzeneacetic Acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-, Hydrochloride
119. Benzeneacetic Acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-, Hydrochloride, (+-)-
Molecular Weight | 538.1 g/mol |
---|---|
Molecular Formula | C32H40ClNO4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 10 |
Exact Mass | 537.2645865 g/mol |
Monoisotopic Mass | 537.2645865 g/mol |
Topological Polar Surface Area | 81 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 678 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Allegra |
PubMed Health | Fexofenadine/Pseudoephedrine (By mouth) |
Drug Classes | Antihistamine, Less-Sedating/Decongestant Combination, Antihistamine/Decongestant Combination |
Drug Label | Fexofenadine hydrochloride, the active ingredient of ALLEGRA Tablets, ALLEGRA ODT and ALLEGRA Oral Suspension, is a histamine H1-receptor antagonist with the chemical name ()-4-[1 hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-,-dim... |
Active Ingredient | Fexofenadine hydrochloride |
Dosage Form | Suspension |
Route | Oral |
Strength | 30mg/5ml |
Market Status | Prescription |
Company | Sanofi Aventis Us |
2 of 4 | |
---|---|
Drug Name | Fexofenadine hydrochloride |
Drug Label | Fexofenadine hydrochloride is a histamine H1-receptor antagonist with the chemical name (benzeneacetic acid hydrochloride. It has the following chemical structure:C32H39NO4Molecular Weight: 538.13Fexofenadine hydrochloride is a white to off-white cry... |
Active Ingredient | Fexofenadine hydrochloride |
Dosage Form | Tablet; Suspension |
Route | oral; Oral |
Strength | 180mg; 30mg/5ml; 60mg; 30mg; 30mg/ml |
Market Status | Tentative Approval; Prescription |
Company | Ranbaxy; Aurolife Pharma; Actavis Mid Atlantic; Teva; Dr Reddys Labs; Sandoz; Mylan; Barr |
3 of 4 | |
---|---|
Drug Name | Allegra |
PubMed Health | Fexofenadine/Pseudoephedrine (By mouth) |
Drug Classes | Antihistamine, Less-Sedating/Decongestant Combination, Antihistamine/Decongestant Combination |
Drug Label | Fexofenadine hydrochloride, the active ingredient of ALLEGRA Tablets, ALLEGRA ODT and ALLEGRA Oral Suspension, is a histamine H1-receptor antagonist with the chemical name ()-4-[1 hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-,-dim... |
Active Ingredient | Fexofenadine hydrochloride |
Dosage Form | Suspension |
Route | Oral |
Strength | 30mg/5ml |
Market Status | Prescription |
Company | Sanofi Aventis Us |
4 of 4 | |
---|---|
Drug Name | Fexofenadine hydrochloride |
Drug Label | Fexofenadine hydrochloride is a histamine H1-receptor antagonist with the chemical name (benzeneacetic acid hydrochloride. It has the following chemical structure:C32H39NO4Molecular Weight: 538.13Fexofenadine hydrochloride is a white to off-white cry... |
Active Ingredient | Fexofenadine hydrochloride |
Dosage Form | Tablet; Suspension |
Route | oral; Oral |
Strength | 180mg; 30mg/5ml; 60mg; 30mg; 30mg/ml |
Market Status | Tentative Approval; Prescription |
Company | Ranbaxy; Aurolife Pharma; Actavis Mid Atlantic; Teva; Dr Reddys Labs; Sandoz; Mylan; Barr |
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Histamine H1 Antagonists, Non-Sedating
A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment. (See all compounds classified as Histamine H1 Antagonists, Non-Sedating.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?